Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study

Go back to Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study
Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.59 +0.12 (25.53%)
Previous Close $0.47    52 Week High $0.00 
Open $0.51    52 Week Low $0.00 
Day High $0.68    P/E N/A 
Day Low $0.48    EPS $0.00 
Volume 43,601,128       

Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.59 +0.12 (25.53%)
Previous Close $0.47    52 Week High $0.00 
Open $0.51    52 Week Low $0.00 
Day High $0.68    P/E N/A 
Day Low $0.48    EPS $0.00 
Volume 43,601,128       

Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.59 +0.12 (25.53%)
Previous Close $0.47    52 Week High $0.00 
Open $0.51    52 Week Low $0.00 
Day High $0.68    P/E N/A 
Day Low $0.48    EPS $0.00 
Volume 43,601,128